- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03428815
Effects of Temperature Control Liner Materials on Long-Term Outcomes of Prothesis Use
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: The proposed work will generate evidence-based practice guidance for temperature control liner technologies and allow providers to optimize care to Service members and Veterans with limb loss. Sizeable numbers of Service members and Veterans live with limb loss, mostly due to traumatic musculoskeletal injury. Addressing the resulting functional deficit with prostheses increases the risk for secondary conditions such as pressure sores, impaired blood perfusion, and injuries from accidental falls. Any of those occurrences can render the prosthesis temporarily useless, making it challenging for users to engage in many activities of daily life, including work, exercise, and social participation. Many of the described issues originate at the interface between residual limb and prosthetic socket, where the objectives of sufficient weight distribution and suspension are conflicting with the necessity to facilitate heat exchange and limit contact pressure and friction.
Recently, prosthesis liners that contain phase-change material have become commercially available, holding the promise that the micro climate at the interface between the residual limb skin and the prosthetic socket can be regulated to reduce the users' tendency to sweat. Preliminary studies on these liners indicate that the socket temperatures inside the socket stayed lower and rose slower than in conventional liners. However, the clinical relevance of those findings remains unclear. While (perceived) socket comfort is certainly an important criterion in prosthesis fitting, it may be claimed that only tangible functional benefits are of concern.
Objective/Hypothesis: The purpose of this study is to investigate whether longer (6+ months) periods of use of phase-change material based temperature control liners have clinically meaningful effects.
It is hypothesized that use of phase-change material infused liners will improve prosthesis utilization (measured in days of prostheses use per time), physical performance (measured by 2-minute walk test), and self-reported prosthesis related quality of life (assessed by questionnaire). The research follows the rationale that lower and steadier skin temperatures should result in reduced sweat, friction, skin damage, and prosthesis abandonment. This would encourage users to wear their prosthesis for longer periods of time and for an expanded array of purposes, thus increasing their ability to ambulate and to engage in a greater variety of activities.
Specific Aims:
- To compare phase-change material liners to conventional liners with regard to activity and participation
- To quantify the effect of phase-change material liners on prosthesis related quality of life and physical performance over time
- To investigate the relationship between perceived benefits of phase-change material liners and patient-centric outcomes
Study Design: The proposed study will utilize a double-blind longitudinal cross-over research design. A sample of trans-tibial prosthesis users will be wearing their regular gel or silicone liners for six months and phase-change material liners for another six months in a randomized sequence. Their prostheses will be equipped with activity monitors, and participants will be asked to maintain a record of days when they could not wear their prosthesis due to any perceived issues with their residual limb or socket fit. In 1.5-month intervals, subjects' activity, physical performance, and overall prosthesis assessment will be recorded using standardized methods.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15206
- Bakery Square MSPO labs
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- use of a prosthesis with liner suspension,
- at least one year of prosthesis use,
- a well-fitting socket,
- a matured residual limb (stable limb volume) that has not required socket modifications in the previous year,
- the ability to walk with the prosthesis outdoors without notable limitations (K-Level 3),
- stable weight,
- absence of acute medical conditions that would temporarily affect the ability to use prostheses.
Exclusion Criteria:
- use of a non-standard liner size,
- current use of a PCM liner as the regular suspension system,
- known allergies against liner materials,
- any inability to understand the protocol and to comply with the associated tasks, such as maintaining a log of days when the prosthesis could not be used.
- anticipated provision of a new prosthesis or extended (longer than one month) absences from the region during the study period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PCM liner
Willowwood Smart Temp Liner
|
Liners out of phase change material will be fitted
|
|
Active Comparator: regular liner
User's regular prescribed liner
|
Liners out of phase change material will be fitted
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Days Without Prosthesis
Time Frame: 6 months
|
Days with less than 10% of prosthesis steps than the individual's daily average across the study period.
Days without prosthesis are prorated to a full year (365 days) for comparison purposes.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average Daily Step Count
Time Frame: 6 months per intervention
|
A participant's daily step counts were averaged across days with prosthesis use across each intervention period
|
6 months per intervention
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO17090574
- W81XWH-16-OPORP-PORA (Other Grant/Funding Number: US Dept of Defense)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Diseases
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMalignant Skin Neoplasm | Skin Disorder | Skin NeoplasmUnited States
-
R2 DermatologyCompleted
-
TCI Co., Ltd.Completed
-
Access Business GroupClinical Research LaboratoriesCompleted
-
Molnlycke Health Care ABCompletedPsoriasis | Eczema | Dry Skin; EczemaUnited Kingdom
-
Shanghai EGT Synbio Group Co., Ltd.Completed
-
National University Hospital, SingaporeNot yet recruitingSkin Cancer | Skin Cancer Prevention | Benign Skin Growth
Clinical Trials on Prosthesis suspension liner
-
Seattle Institute for Biomedical and Clinical ResearchUnited States Department of DefenseCompletedLower Extremity AmputationUnited States
-
Liberating Technologies, Inc.Vivonics, Inc.CompletedAmputation | Prosthesis | Prosthesis User | Amputation Stumps | Amputees | Lower Limb Deformities, CongenitalUnited States
-
GI DynamicsCompleted
-
GI DynamicsCompleted
-
VA Puget Sound Health Care SystemActive, not recruitingAmputation | Prosthesis UserUnited States
-
Liberating Technologies, Inc.Vivonics, Inc.TerminatedAmputation | Prosthesis | Prosthesis User | Amputation Stump | Amputees | Lower Limb DeformityUnited States
-
GI DynamicsCompletedObesity | Type 2 DiabetesUnited Kingdom
-
Biomet Nederland BVAtrium Medical CenterTerminatedOsteoarthritisNetherlands
-
Texas Woman's UniversityHarris County Hospital District; DJO IncorporatedCompletedPain | Sleep | HIV | Peripheral Neuropathy | AIDSUnited States